Evidence map›Paper›PMID 29662303›Full record

Trial reportDrug design, development and therapy2018

The effectiveness of long-term course of Sterimar Mn nasal spray for treatment of the recurrence rates of acute allergic rhinitis in patients with chronic allergic rhinitis.

Michele Grasso, Marco de Vincentiis, Griselda Agolli, Francesco Cilurzo, Raffaele Grasso

Open access · goldAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Drug design, development and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michele GrassoENT Department, Head and Neck Surgery, University "Sapienza", Rome, Italy.
Marco de VincentiisENT Department, Head and Neck Surgery, University "Sapienza", Rome, Italy.
Griselda AgolliENT Department, Head and Neck Surgery, University "Sapienza", Rome, Italy.
Francesco CilurzoENT Department, Head and Neck Surgery, Lamezia Terme Hospital, Calabria, Italy.
Raffaele GrassoENT Department, Head and Neck Surgery, Lamezia Terme Hospital, Calabria, Italy.
Sapienza University of Rome · ITBioAge (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe "cost of illness" of the acute allergic rhinitis (AR) episodes in patients with chronic AR is very high in terms of therapy and quality of life. AR represents a worldwide health problem; despite the fact that many standardized treatments have been proposed and used, the recurrence rate of acute rhinitis episodes in springtime is always higher. MATERIALS AND

methodsSixty consecutive patients (13 F and 17 M in group A, 15 F and 15 M in group B;

resultsA 5 months course treatment with the nasal Sterimar Mn was able to decrease, significantly (

conclusionThis study shows the effectiveness of the use of Sterimar Mn for a 5 months therapy in terms of reduction of the number of episodes of acute AR and effectiveness of intrasubject improvement of Visual Analog Scale (quality of life).

Indexed as

Nasal SpraysAcute DiseaseAdministration, IntranasalAdolescentAdultAgedAged, 80 and overChronic DiseaseFemaleHumansMaleManganeseMiddle AgedProspective StudiesRhinitis, AllergicYoung AdultManganeseNasal Spraysacute allergic rhinitischronic allergic rhinitisnasal detersionpreventionSterimar Mn

Identifiers

PMID29662303
PMCPMC5892953
OpenAlexW2795603546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.